3M announced 12 new color options for its Littmann Classic III line of stethoscopes. The colors range from Plum to Pearl Pink to Caribbean Blue and Lime Green. There are also four new color combinations with smoke and rainbow chestpiece finishes.
The National Institute for Health and Care Excellence (NICE) has recommended a new treatment to help patients suffering from blood clots in the legs and lungs.
Two top Las Vegas cardiologists, Sean Ameli, M.D., and Berge Dadourian, M.D., announced that the Ameli | Dadourian Heart Center has transitioned to a concierge cardiology practice. Located in Tivoli Village in Summerlin, the Ameli | Dadourian Heart Center offers access to high-quality cardiology care featuring same- or next-day appointments, phone calls answered by friendly staff and ongoing preventative educational services.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
HeartWare International Inc. announced that enrollment in the ENDURANCE2 destination therapy clinical trial has been completed. ENDURANCE2 is the largest destination therapy clinical trial of a ventricular assist device conducted to date and is designed to evaluate patients implanted with the HeartWare Ventricular Assist Device (HVAD) for long-term use as destination therapy in the United States. Data from the ENDURANCE program are expected to form the basis for a pre-market approval (PMA) application seeking approval of the HeartWare System for destination therapy.
On July 2, Cook Medical initiated a voluntary recall of 2,239 lots of beacon tip angiographic catheters. A total of 95,167 devices globally are subject to this recall. The products include specific versions and lot numbers of the Torcon NB Advantage beacon tip catheters, Royal Flush Plus beacon tip high-flow catheters and Slip-Cath beacon tip catheters.
Biotronik announced the first enrollments in the BIO|GUARD-MI1 study. The study will investigate whether the early detection of cardiac arrhythmias offered by BioMonitor, and subsequent treatments, reduce the likelihood of major adverse cardiovascular events (MACE). The study will, for the first time ever, examine patients with relatively preserved left ventricular ejection fraction (LVEF > 35 percent), who have experienced acute myocardial infarction (AMI).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Boston Scientific has become a significant shareholder and will become the exclusive worldwide sales and marketing representative for Preventice Solutions for cardiology-related diagnostic and monitoring offerings.
Several common measures obtained from electrocardiograms (ECGs) may help clinicians determine a kidney disease patient’s risk of dying from heart disease. The findings, which are published in a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN), may be important for preserving kidney patients’ heart health.
The Technology Partnership (TTP), a U.K.-based research and product development company, has made major advances in the use of elastography, a medical imaging technique that maps elastic properties of soft tissue to provide vital diagnostic information during surgery. The new breakthrough could be used for surgical processes such as treating abnormal heart rhythms caused by atrial fibrillation, killing or removing cancerous or damaged tissue, or simply navigating around the body during an operation.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The American College of Cardiology (ACC) has announced that Boehringer Ingelheim is the newest industry sponsor of The Diabetes Collaborative Registry. The registry is an interdisciplinary effort led by the college in partnership with the American Diabetes Association, the American College of Physicians, the American Association of Clinical Endocrinologists and the Joslin Diabetes Center.
Mayo Clinic is announcing results of a study on the effectiveness of left-ventricular assist devices (LVAD) in treating patients with a form of cardiomyopathy called restrictive cardiomyopathy (RCM). The Mayo Clinic study, which is the largest study of its kind to date, demonstrates that LVAD devices are a viable and accessible option for treating patients with RCM, who would otherwise see their health deteriorate or who may not survive. The study suggests criteria that clinicians can use for successful implementation of these devices in RCM.
Merit Medical Systems Inc. announced that it has expanded its Europe, Middle East and Africa (EMEA) distribution center and corporate office in Maastricht, the Netherlands.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
DAIC Editor Dave Fornell shares some of the most innovative new technologies shown on the expo floor and discusses in ...
The American College of Cardiology (ACC) convened leaders in all aspects of healthcare the week of July 27 for a two-day Population Health Retreat to discuss how to focus resources to prevent heart disease and related health conditions.
August 6, 2015 — IBM announced that its Watson Health Cloud will gain the ability to “see” following the planned ...